All Stories

  1. Development of Potential Antidiabetic Agents using 2D and 3D QSAR, Molecular Docking and ADME Properties In-silico Studies of α-amylase Inhibitors

    Article • Letters in Drug Design & Discovery, December 2024, Bentham Science Publishers

    Dr Aniket Pradip Sarkate, DR SHASHIKANT BHANDARI, Mr. Kalusing Padvi

  2. A Review: Exploring Synthetic Schemes and Structure-activity Relationship (SAR) Studies of Mono-carbonyl Curcumin Analogues for Cytotoxicity Inhibitory Anticancer Activity

    Article • Current Organic Synthesis, December 2023, Bentham Science Publishers

    DR SHASHIKANT BHANDARI, Shital Patil, Dr Aniket Pradip Sarkate

  3. Designing and In silico Studies of Novel Hybrid of 1,3,4-oxadiazolechalcone Derivatives as EGFR Inhibitors

    Article • Current Drug Discovery Technologies, November 2023, Bentham Science Publishers

    DR SHASHIKANT BHANDARI, Shital Patil

  4. Molecular modeling and docking studies of thiazolyl-pyrazole as EGFR inhibitors

    Article • Letters in Drug Design & Discovery, October 2017, Bentham Science Publishers

    DR SHASHIKANT BHANDARI, Sunayana Ghodgaonkar